Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Assure Tech (Hangzhou) Co., Ltd. (688075.SS)

35.97
-0.72
(-1.96%)
At close: 3:00:03 PM GMT+8
Loading Chart for 688075.SS
  • Previous Close 36.69
  • Open 36.13
  • Bid 35.96 x --
  • Ask 35.97 x --
  • Day's Range 35.96 - 36.70
  • 52 Week Range 30.62 - 47.00
  • Volume 493,692
  • Avg. Volume 655,630
  • Market Cap (intraday) 4.721B
  • Beta (5Y Monthly) 0.96
  • PE Ratio (TTM) 51.39
  • EPS (TTM) 0.70
  • Earnings Date --
  • Forward Dividend & Yield 0.80 (2.18%)
  • Ex-Dividend Date Nov 11, 2024
  • 1y Target Est --

Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of diagnostic reagents, POCT, and biological materials. Its products are used in drug of abuse tests, infectious disease tests, fertility tests, tumor markers tests, cardiac markers tests, biochemical tests, allergy tests, and chronic disease series. Assure Tech (Hangzhou) Co., Ltd. was founded in 2008 and is based in Hangzhou, China.

www.diareagent.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 688075.SS

View More

Performance Overview: 688075.SS

Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

688075.SS
2.47%
SSE Composite Index (000001.SS)
1.89%

1-Year Return

688075.SS
11.48%
SSE Composite Index (000001.SS)
6.47%

3-Year Return

688075.SS
53.74%
SSE Composite Index (000001.SS)
10.52%

5-Year Return

688075.SS
15.31%
SSE Composite Index (000001.SS)
17.02%

Compare To: 688075.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688075.SS

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    4.66B

  • Enterprise Value

    2.65B

  • Trailing P/E

    51.68

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.91

  • Price/Book (mrq)

    0.91

  • Enterprise Value/Revenue

    4.48

  • Enterprise Value/EBITDA

    10.00

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    36.22%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    3.92%

  • Revenue (ttm)

    555.15M

  • Net Income Avi to Common (ttm)

    201.09M

  • Diluted EPS (ttm)

    0.70

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.03B

  • Total Debt/Equity (mrq)

    0.19%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 688075.SS

View More

Company Insights: 688075.SS

Research Reports: 688075.SS

View More

People Also Watch